- Angelina Jolie stunt double sues News Corp over hacking
- Kanye West wins over critics with 'daring' new album 'Yeezus'
- Shares choppy, dollar steady as Fed meets
- Journalist who brought down U.S. general is killed in Los Angeles car crash
- Massachusetts police search NFL player's home in homicide probe: report
UPDATE 1-AtriCure's heart device gets FDA approval; shares up
* To launch device later this month
* Shares up 17 pct after market
June 14 (Reuters) - AtriCure Inc (ATRC.O) said U.S. health regulators approved its device that helps prevent blood clots in the heart, sending its shares up 17 percent.
The company said its AtriClip system prevents blood from entering and forming clots in the left atrial appendage, a hollow sac-like structure attached to the heart's left upper chamber, during irregular heart beats.
AtriCure plans to launch the device later this month in the United States.
Shares of the company were up 90 cents at $6.13 in after-market trade. They closed at $5.23 Monday on Nasdaq. (Reporting by Anand Basu in Bangalore; Editing by Vinu Pilakkott)
- Tweet this
- Share this
- Digg this